These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8503669)

  • 1. Nasal IgA response in wheezy infants.
    Balfour-Lynn IM; Valman B; Silverman M; Webster AD
    Arch Dis Child; 1993 Apr; 68(4):472-6. PubMed ID: 8503669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concentrations of IgA and free secretory piece in the nasal secretions of patients with recurrent respiratory infections.
    Stanley PJ; Cole PJ
    Clin Exp Immunol; 1985 Jan; 59(1):197-202. PubMed ID: 3918818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of acute respiratory tract infections among children in a kibbutz: the role of secretory IgA and serum immunoglobulins.
    Yodfat Y; Silvian I
    J Infect Dis; 1977 Jul; 136(1):26-30. PubMed ID: 886205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine].
    Henocq A; Moreau C; Mallet E; Sauger F; de Menibus CH
    Ann Otolaryngol Chir Cervicofac; 1985; 102(5):373-5. PubMed ID: 4037622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants.
    Balfour-Lynn IM; Valman HB; Wellings R; Webster AD; Taylor GW; Silverman M
    Clin Exp Allergy; 1994 Feb; 24(2):121-6. PubMed ID: 8187027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of cytokines and inflammatory mediators in samples of nasopharyngeal secretions with unknown dilution.
    Heikkinen T; Shenoy M; Goldblum RM; Chonmaitree T
    Pediatr Res; 1999 Feb; 45(2):230-4. PubMed ID: 10022595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secretory IgA and infantile respiratory pathology].
    del Castillo Aguas G; García Hernández G; Villa Asensi JR; Ferriz J; Guerra F; Nogales Espert A
    An Esp Pediatr; 1988 Dec; 29(6):428-30. PubMed ID: 3245639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases.
    Hupin C; Rombaux P; Bowen H; Gould H; Lecocq M; Pilette C
    Allergy; 2013 Dec; 68(12):1589-97. PubMed ID: 24117840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The local antibody response to R.S. virus infection in the respiratory tract.
    Scott R; Gardner PS
    J Hyg (Lond); 1974 Feb; 72(1):111-20. PubMed ID: 4206147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory IgA and serum type IgA in nasal secretion and antibody activity against the M protein.
    Kurono Y; Mogi G
    Ann Otol Rhinol Laryngol; 1987; 96(4):419-24. PubMed ID: 3304089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stimulation of immunologic functional reserves of respiratory mucosa in children susceptible to infection].
    Werner E; Zips M; Meyer P; Wiersbitzky S
    Padiatr Grenzgeb; 1987; 26(6):433-8. PubMed ID: 3441395
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions.
    Robertson J; Caldwell JR; Castle JR; Waldman RH
    J Immunol; 1976 Sep; 117(3):900-3. PubMed ID: 956659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa.
    Brandtzaeg P; Karlsson G; Hansson G; Petruson B; Björkander J; Hanson LA
    Clin Exp Immunol; 1987 Mar; 67(3):626-36. PubMed ID: 3301101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of 11S IgA in nasal secretions in the monitoring of local immunomodulating therapy].
    Bussi M; Carlevato MT; Battaglio S; Galeazzi E; Omedé P; Cortesina G
    Acta Otorhinolaryngol Ital; 1991; 11(1):35-43. PubMed ID: 1897369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental regulation of type 1 and type 3 interferon production and risk for infant infections and asthma development.
    Holt PG; Mok D; Panda D; Renn L; Fabozzi G; deKlerk NH; Kusel MMH; Serralha M; Hollams EM; Holt BJ; Sly PD; Rabin RL
    J Allergy Clin Immunol; 2019 Mar; 143(3):1176-1182.e5. PubMed ID: 30217468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local immune system of nasal nucosa in inflammation. IgA distribution and secretory activity.
    Nakashima T; Hamashima Y
    Ann Otol Rhinol Laryngol; 1980; 89(2 Pt 1):140-6. PubMed ID: 6989305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions.
    Raphael GD; Druce HM; Baraniuk JN; Kaliner MA
    Am Rev Respir Dis; 1988 Aug; 138(2):413-20. PubMed ID: 3057965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration of immunoglobulins in nasal secretion from children with recurrent infections in the upper airways.
    Mygind N; Wihl JA
    Acta Otolaryngol; 1976; 82(3-4):216-8. PubMed ID: 983678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory and serum IgA in children with protein-calorie malnutrition.
    Sirisinha S; Suskind R; Edelman R; Asvapaka C; Olson RE
    Pediatrics; 1975 Feb; 55(2):166-70. PubMed ID: 804157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.